Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ENANTA PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC previously held 0 shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$2.6M
Total Shares Change
-198,212
Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, BANQUE PICTET & CIE SA
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $15.16 |
0 |
| 2025-Q2 | Decreased | 149,178 | -6.5% | $1.1M | 0.0% | $7.50 | 0 |
| 2025-Q1 | Decreased | 159,497 | -0.1% | $880,423 | 0.0% | $5.71 | 0 |
| 2024-Q4 | Decreased | 159,729 | -6.4% | $918,442 | 0.0% | $5.85 | 0 |
| 2024-Q3 | Decreased | 170,615 | -13.9% | $1.8M | 0.0% | $10.05 | 0 |
| 2024-Q2 | Decreased | 198,212 | -4.8% | $2.6M | 0.0% | $12.97 | 0 |